Compare WH & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WH | BCPC |
|---|---|---|
| Founded | 2017 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.6B |
| IPO Year | 2017 | 1995 |
| Metric | WH | BCPC |
|---|---|---|
| Price | $79.86 | $159.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | $94.10 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 1.1M | 181.9K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.04% | 0.55% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | 0.80 | ★ 1.25 |
| Revenue | ★ $1,429,000,000.00 | $799,023,000.00 |
| Revenue This Year | $6.86 | $8.47 |
| Revenue Next Year | $5.83 | $4.89 |
| P/E Ratio | ★ $100.81 | $129.36 |
| Revenue Growth | 1.49 | ★ 13.56 |
| 52 Week Low | $69.21 | $139.17 |
| 52 Week High | $92.69 | $183.90 |
| Indicator | WH | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 35.08 |
| Support Level | $79.69 | $159.00 |
| Resistance Level | $82.13 | $160.65 |
| Average True Range (ATR) | 2.60 | 4.42 |
| MACD | -0.50 | -0.60 |
| Stochastic Oscillator | 2.38 | 11.76 |
As of Dec. 31, 2025, Wyndham Hotels & Resorts operates 869,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Ramada is the largest brand, representing around 14% of all rooms, with Days Inn (13%) and Super 8 (10%) the next two largest brands, as of the end of 2025. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represented 58% of total rooms in 2025.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.